Literature DB >> 11988932

Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.

Adriano Piattelli1, Corrado Rubini, Massimiliano Fioroni, Giovanna Iezzi, Alfredo Santinelli.   

Abstract

PURPOSE: Loss of normal p53 is correlated to the progression of several preneoplastic lesions to neoplasms, and overexpression of bcl-2 determines an alteration of programmed cell death. There is an increased awareness of the importance of apoptosis in cancerogenesis, and a strong correlation of Ki-67 with high tumor grade has been reported.
MATERIALS AND METHODS: The aim of our study was to investigate immunohistochemically the expression and relationship of p53, bcl-2, MIB-1, and the apoptotic index (AI) in normal oral epithelium, leukoplakia, dysplasia, and oral squamous cell carcinoma.
RESULTS: A strong correlation was found between p53 overexpression and cell proliferation (MIB-1) and the AI. An inverse relationship was found between bcl-2 expression and MIB-1 and AI. A significant inverse relationship was found between p53 and bcl-2. A good positive correlation was present between AI and MIB-1 expression.
CONCLUSIONS: Apoptosis could be important to help to understand oral carcinogenesis. Copyright 2002 American Association of Oral and Maxillofacial Surgeons

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11988932     DOI: 10.1053/joms.2002.31851

Source DB:  PubMed          Journal:  J Oral Maxillofac Surg        ISSN: 0278-2391            Impact factor:   1.895


  12 in total

1.  Prognostic value of activated Akt expression in oral squamous cell carcinoma.

Authors:  J Lim; J-H Kim; J-Y Paeng; M-J Kim; S-D Hong; J-I Lee; S-P Hong
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

2.  Apoptosis in primary oral squamous cell carcinomas without lymph node metastases.

Authors:  Zhi Yan; Guomin Wang; Zhiyong Xie; Handong Zhang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

3.  Predicting transition from oral pre-malignancy to malignancy via Bcl-2 immuno-expression: Evidence and lacunae.

Authors:  Ruby Dwivedi; Shaleen Chandra; Divya Mehrotra; Vineet Raj; Rahul Pandey
Journal:  J Oral Biol Craniofac Res       Date:  2020-07-19

4.  Predictive Role of p53 Protein as a Single Marker or Associated to Ki67 Antigen in Oral Carcinogenesis.

Authors:  L Montebugnoli; L Felicetti; D B Gissi; F Cervellati; D Servidio; C Marchetti; C Prati; F Flamminio; M P Foschini
Journal:  Open Dent J       Date:  2008-02-21

5.  Expression of Bcl-2 and MIB-1 Markers in Oral Squamous Cell Carcinoma (OSCC)- A Comparative Study.

Authors:  Jessica Garewal; Ripin Garewal; Keya Sircar
Journal:  J Clin Diagn Res       Date:  2014-07-20

6.  Clinicopathological correlation of Bcl-2 oncoprotein expression in oral precancer and cancer.

Authors:  Vandana Arya; Subash Singh; M Jonathan Daniel
Journal:  J Oral Biol Craniofac Res       Date:  2016-01-19

7.  Expression of p53 protein and ki-67 antigen in oral premalignant lesions and oral squamous cell carcinomas: An immunohistochemical study.

Authors:  S Humayun; V Ram Prasad
Journal:  Natl J Maxillofac Surg       Date:  2011-01

8.  Benign proliferative epithelial lesions of oral mucosa are infrequently associated with α-, β-, or γ human papillomaviruses.

Authors:  Sirli Kerge; Jessi Vuorinen; Saija Hurme; Tero Soukka; Tarik Gheit; Massimo Tommasino; Stina Syrjänen; Jaana Rautava
Journal:  Laryngoscope Investig Otolaryngol       Date:  2018-12-03

9.  Salivary apoptotic cells in oral (pre-) cancer as a potential diagnostic means.

Authors:  Jasdeep Kaur; Constantinus Politis; Reinhilde Jacobs
Journal:  J Clin Exp Dent       Date:  2015-07-01

10.  Immunohistochemical evaluation of oral epithelial dysplasia using cyclin-D1, p27 and p63 expression as predictors of malignant transformation.

Authors:  Abilasha Ramasubramanian; Pratibha Ramani; Herald J Sherlin; Priya Premkumar; Anuja Natesan; Chandrasekar Thiruvengadam
Journal:  J Nat Sci Biol Med       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.